Assignee
MIRA DX INC
US·3 granted patents·4 pending applications·0 citations·filing 2015–2025
Top patents by PatentIndex Score
7 records- 0173US12297509B2Biomarkers for predicting tumor response to and toxicity of immunotherapyMIRA DX INC·Filed 2023·Granted May 13, 2025·0 cites·15 claims
- 0267US2025305062A1Biomarkers for predicting tumor response to and toxicity of immunotherapyMIRA DX INC·Filed 2025·Application pending·0 cites
- 0363US11578371B2Biomarkers for predicting tumor response to and toxicity of immunotherapyMIRA DX INC·Filed 2018·Granted Feb 14, 2023·0 cites·14 claims
- 0462US2022088033A1Methods for treating or preventing cancer in a kras-variant patient and for diagnosing risk of developing multiple primary breast tumorsMIRA DX INC·Filed 2021·Application pending·0 cites
- 0549US2023103419A1Biomarkers for predicting toxicity of radiationMIRA DX INC·Filed 2021·Application pending·0 cites
- 0648US10278976B2Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumorsMIRA DX INC·Filed 2015·Granted May 7, 2019·0 cites·4 claims
- 0738US2020325234A1Immune-based treatment of kras-variant cancer patientsMIRA DX INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MIRA DX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →